Pregnancy: Administration of L- Ornithine-L-Aspartate granules during pregnancy should therefore be avoided. If, however, treatment with L- Ornithine-L-Aspartate granules is considered necessary, careful consideration should be given to the benefit versus risk ratio.
Lactation: It is not known whether L- Ornithine-L-Aspartate is excreted into breast milk. Administration of L- Ornithine-L-Aspartate granules should therefore be avoided during lactation. If, however, treatment with L- Ornithine-L-Aspartate granules is considered necessary, careful consideration should be given to the benefit versus risk ratio.